Canada Research Roundup: Acadian Timber, Docebo, Trillium Therapeutics

Docebo

09/12/2020 09:40

Dec 9 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Acadian Timber, Docebo and Trillium Therapeutics, on Wednesday. 
    
    HIGHLIGHTS       
    
     * Acadian Timber Corp  ADN.TO : Credit Suisse cuts to underperform from neutral
     * Docebo Inc  DCBO.TO : TD Securities raises price target to C$77 from C$66
     * Trillium Therapeutics Inc  TRIL.TO : Jonestrading raises price target to $25 from $20
    
       
Following is a summary of research actions on Canadian companies reported by Reuters on
Wednesday. Stock entries are in alphabetical order. 
    
     * Acadian Timber Corp  ADN.TO : Credit Suisse cuts to underperform from neutral
     * Air Canada  AC.TO : RBC raises target price to C$30 from C$23
     * Alaris Equity Partners Income Trust  AD_u.TO : CIBC raises PT to C$19 from C$15.50
     * Alaris Equity Partners Income Trust  AD_u.TO : CIBC raises to outperformer from neutral
     * Alaris Equity Partners Income Trust  AD_u.TO : Scotiabank raises PT to C$16 from C$15
     * ATS Automation Tooling Systems Inc  ATA.TO : National Bank of Canada raises PT to C$28 from C$22
     * Ats Automation Tooling Systems Inc  ATA.TO : TD Securities raises PT to C$31 from C$28
     * Docebo Inc  DCBO.TO : TD Securities raises price target to C$77 from C$66
     * Enbridge Inc  ENB.TO : CIBC cuts target price to C$47 from C$48
     * GFL Environmental Inc  GFL.TO : TD Securities raises price target to C$36 from C$32
     * Trillium Therapeutics Inc  TRIL.TO : Jonestrading raises price target to $25 from $20
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))